Clobazam and diazepam in anxiety
Karl Rickels, Avi S. Brown, David Cohen, Harvey Harris, Aaron Hurowitz, Ellis J. Lindenbaum, Harris A. Ross, Robert Weinstock, Kenneth Wiseman, Michael Zal
Abstract
Karl Rickels, Avi S. Brown, David Cohen, Harvey Harris, Aaron Hurowitz, Ellis J. Lindenbaum, Harris A. Ross, Robert Weinstock, Kenneth Wiseman, Michael Zal
Abstract
The anxiolytic effects of clobazam, diazepam, and placebo were compared in a 4-wk double-blind study of 159 anxious outpatients, primarily from family practice. Clobazam (30 to 80 mg/day) and diazepam (15 to 40 mg/day) were found to induce similar side effect, primarily sedation, and although both active drugs induced greater clinical improvement than placebo, clobazam induced the largest degree of improvement in most aspects. It was speculated that the relatively high daily dosage of diazepam may have been contributed to these results.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The anxiolytic effects of clobazam, diazepam, and placebo were compared in a 4-wk double-blind study of 159 anxious outpatients, primarily from family practice. Clobazam (30 to 80 mg/day) and diazepam (15 to 40 mg/day) were found to induce similar side effect, primarily sedation, and although both active drugs induced greater clinical improvement than placebo, clobazam induced the largest degree of improvement in most aspects. It was speculated that the relatively high daily dosage of diazepam may have been contributed to these results.
Key concepts: Clobazam, Diazepam, Anxiolytic, Sedation, Placebo, Anti-Anxiety Agents, Clinical pharmacology, Anxiety